Homopeptide timeline
Every Homopeptide batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| HOMO-2608-A9045 | Ipamorelin | 27 Aug 2026 | 2026-Q3 | 12 | 99.54 | 0.67 | 99.70 | +0.16 | |
| HOMO-2607-P1246 | IGF-1 LR3 | 10 Jul 2026 | 2026-Q3 | 1 | 98.34 | n<2 | 99.35 | +1.01 | |
| HOMO-2605-S1342 | Semax | 26 May 2026 | 2026-Q3 | 1 | 99.44 | n<2 | 99.90 | +0.46 | |
| HOMO-2605-V9833 | Retatrutide | 02 May 2026 | 2026-Q3 | 4 | 98.95 | 0.92 | 98.99 | +0.04 | |
| HOMO-2604-D1599 | SS-31 (Elamipretide) | 29 Apr 2026 | 2026-Q3 | 2 | 99.77 | 0.32 | 99.90 | +0.13 | |
| HOMO-2604-M2254 | Semaglutide | 14 Apr 2026 | 2026-Q2 | 5 | 98.95 | 1.34 | 99.33 | +0.38 | |
| HOMO-2604-X8921 | Semaglutide | 11 Apr 2026 | 2026-Q3 | 12 | 99.43 | 1.12 | 99.50 | +0.07 | |
| HOMO-2603-C1382 | N-Acetyl Semax Amide | 27 Mar 2026 | 2026-Q2 | 3 | 99.22 | 0.75 | 99.55 | +0.33 | |
| HOMO-2602-Y2822 | SLU-PP-332 | 27 Feb 2026 | 2026-Q3 | 8 | 99.51 | 1.10 | 99.90 | +0.39 | |
| HOMO-2602-E2761 | Liraglutide | 25 Feb 2026 | 2026-Q2 | 8 | 99.93 | 0.50 | 99.90 | -0.03 | |
| HOMO-2602-S8315 | Semax | 24 Feb 2026 | 2026-Q1 | 12 | 99.74 | 0.76 | 100.00 | +0.26 | |
| HOMO-2602-V9076 | Glucagon | 20 Feb 2026 | 2026-Q2 | 1 | 99.85 | n<2 | 99.90 | +0.05 | |
| HOMO-2602-E9033 | GHRP-2 | 14 Feb 2026 | 2026-Q2 | 5 | 99.62 | 0.54 | 99.90 | +0.28 | |
| HOMO-2602-G1280 | LL-37 | 09 Feb 2026 | 2026-Q3 | 12 | 99.30 | 1.09 | 99.78 | +0.48 | |
| HOMO-2602-K9510 | ARA-290 | 07 Feb 2026 | 2026-Q1 | 1 | 99.74 | n<2 | 99.90 | +0.16 | |
| HOMO-2602-R8195 | Hexarelin | 06 Feb 2026 | 2026-Q2 | 3 | 99.93 | 0.04 | 99.90 | -0.03 | |
| HOMO-2601-N9196 | Tirzepatide | 29 Jan 2026 | 2026-Q2 | 5 | 98.77 | 1.07 | 98.87 | +0.10 | |
| HOMO-2601-J8878 | Retatrutide | 19 Jan 2026 | 2026-Q1 | 4 | 98.89 | 0.99 | 99.15 | +0.26 | |
| HOMO-2601-T8238 | ARA-290 | 16 Jan 2026 | 2026-Q2 | 2 | 99.75 | 0.36 | 99.90 | +0.15 | |
| HOMO-2601-D8205 | Semax | 09 Jan 2026 | 2026-Q1 | 2 | 99.93 | 0.00 | 99.90 | -0.03 | |
| HOMO-2512-Y1524 | Semax | 29 Dec 2025 | 2026-Q1 | 8 | 99.55 | 0.98 | 99.90 | +0.35 | |
| HOMO-2512-D1047 | Retatrutide | 22 Dec 2025 | 2026-Q2 | 3 | 99.11 | 1.14 | 99.04 | -0.07 | |
| HOMO-2512-A1223 | Epitalon | 22 Dec 2025 | 2026-Q2 | 2 | 99.65 | 0.57 | 99.90 | +0.25 | |
| HOMO-2512-D1150 | CJC-1295 (no DAC) | 08 Dec 2025 | 2026-Q1 | 7 | 99.33 | 1.37 | 99.90 | +0.57 | |
| HOMO-2512-V9618 | PT-141 (Bremelanotide) | 01 Dec 2025 | 2026-Q1 | 2 | 99.34 | 0.04 | 99.79 | +0.45 | |
| HOMO-2511-V9695 | Afamelanotide | 25 Nov 2025 | 2026-Q1 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| HOMO-2511-M1199 | Melanotan II | 14 Nov 2025 | 2026-Q1 | 12 | 99.06 | 1.50 | 99.90 | +0.84 | |
| HOMO-2511-G9197 | Semaglutide | 11 Nov 2025 | 2025-Q4 | 3 | 99.77 | 0.38 | 99.90 | +0.13 | |
| HOMO-2511-C9607 | Semaglutide | 01 Nov 2025 | 2026-Q1 | 4 | 99.13 | 0.58 | 99.28 | +0.15 | |
| HOMO-2510-E8656 | Tirzepatide | 10 Oct 2025 | 2025-Q4 | 9 | 98.76 | 1.83 | 99.15 | +0.39 | |
| HOMO-2509-X1081 | Leuprolide | 30 Sep 2025 | 2025-Q4 | 1 | 99.16 | n<2 | 98.94 | -0.22 | |
| HOMO-2509-M1537 | Dihexa | 29 Sep 2025 | 2026-Q1 | 1 | 99.58 | n<2 | 100.00 | +0.42 | |
| HOMO-2509-F1941 | Semaglutide | 27 Sep 2025 | 2025-Q4 | 16 | 99.62 | 1.24 | 99.90 | +0.28 | |
| HOMO-2509-U2115 | Tirzepatide | 26 Sep 2025 | 2025-Q4 | 10 | 98.66 | 1.08 | 99.27 | +0.61 | |
| HOMO-2509-K9821 | Afamelanotide | 06 Sep 2025 | 2026-Q1 | 5 | 99.12 | 0.85 | 99.79 | +0.67 | |
| HOMO-2508-W1724 | GHRP-6 | 26 Aug 2025 | 2025-Q4 | 14 | 99.93 | 0.43 | 99.90 | -0.03 | |
| HOMO-2508-A1964 | Melanotan II | 25 Aug 2025 | 2025-Q4 | 5 | 99.24 | 0.66 | 99.50 | +0.26 | |
| HOMO-2508-N8842 | Leuprolide | 23 Aug 2025 | 2026-Q1 | 7 | 99.69 | 0.73 | 100.00 | +0.31 | |
| HOMO-2508-K2535 | Semaglutide | 12 Aug 2025 | 2025-Q4 | 12 | 99.04 | 1.68 | 99.47 | +0.43 | |
| HOMO-2508-Y8363 | Retatrutide | 03 Aug 2025 | 2025-Q4 | 8 | 98.11 | 0.77 | 98.78 | +0.67 | |
| HOMO-2508-U9007 | Retatrutide | 02 Aug 2025 | 2025-Q3 | 13 | 98.58 | 1.92 | 99.41 | +0.83 | |
| HOMO-2507-S1591 | Melanotan II | 27 Jul 2025 | 2025-Q4 | 1 | 99.80 | n<2 | 99.81 | +0.01 | |
| HOMO-2507-L1962 | TB-500 | 22 Jul 2025 | 2025-Q4 | 3 | 99.42 | 0.20 | 99.90 | +0.48 | |
| HOMO-2507-B2039 | SS-31 (Elamipretide) | 22 Jul 2025 | 2025-Q4 | 10 | 99.15 | 1.44 | 99.81 | +0.66 | |
| HOMO-2507-D8818 | Selank | 04 Jul 2025 | 2025-Q3 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| HOMO-2506-M1846 | Semaglutide | 27 Jun 2025 | 2025-Q3 | 10 | 99.00 | 1.66 | 99.37 | +0.37 | |
| HOMO-2506-V8763 | Semaglutide | 16 Jun 2025 | 2025-Q3 | 7 | 98.62 | 0.86 | 99.19 | +0.57 | |
| HOMO-2506-L9801 | MK-677 (Ibutamoren mesylate) | 07 Jun 2025 | 2025-Q4 | 6 | 99.88 | 0.15 | 99.90 | +0.02 | |
| HOMO-2505-X2210 | Semaglutide | 29 May 2025 | 2025-Q3 | 3 | 99.11 | 0.70 | 98.95 | -0.16 | |
| HOMO-2505-A1799 | GHRP-6 | 28 May 2025 | 2025-Q4 | 3 | 99.93 | 0.18 | 100.50 | +0.57 | |
| HOMO-2505-N2173 | Semaglutide | 25 May 2025 | 2025-Q4 | 10 | 98.99 | 0.95 | 99.40 | +0.41 | |
| HOMO-2505-T8504 | GHRP-2 | 17 May 2025 | 2025-Q4 | 6 | 99.53 | 0.78 | 99.42 | -0.11 | |
| HOMO-2505-N9201 | Melanotan II | 16 May 2025 | 2025-Q4 | 8 | 98.90 | 0.86 | 99.43 | +0.53 | |
| HOMO-2505-V8950 | Semaglutide | 05 May 2025 | 2025-Q3 | 9 | 98.64 | 1.41 | 98.72 | +0.08 | |
| HOMO-2505-F2001 | BPC-157 | 05 May 2025 | 2025-Q2 | 10 | 99.70 | 0.59 | 99.90 | +0.20 | |
| HOMO-2504-G9629 | GHRP-6 | 19 Apr 2025 | 2025-Q2 | 13 | 99.91 | 0.48 | 99.90 | -0.01 | |
| HOMO-2504-G1782 | TB-500 | 05 Apr 2025 | 2025-Q3 | 9 | 99.11 | 1.12 | 99.50 | +0.39 | |
| HOMO-2502-U9233 | Tirzepatide | 27 Feb 2025 | 2025-Q2 | 4 | 98.42 | 0.73 | 98.71 | +0.29 | SHARED BULK |
| HOMO-2502-H1007 | Melanotan II | 23 Feb 2025 | 2025-Q1 | 11 | 99.76 | 0.77 | 99.90 | +0.14 | |
| HOMO-2502-U2648 | Semaglutide | 19 Feb 2025 | 2025-Q2 | 4 | 99.35 | 0.40 | 99.71 | +0.36 | |
| HOMO-2501-D9638 | Semaglutide | 14 Jan 2025 | 2025-Q1 | 6 | 99.20 | 0.75 | 99.90 | +0.70 | |
| HOMO-2501-D9486 | L-Glutathione (reduced) | 09 Jan 2025 | 2025-Q1 | 5 | 98.83 | 0.80 | 99.61 | +0.78 | SHARED BULK |
| HOMO-2501-A1307 | Semaglutide | 05 Jan 2025 | 2025-Q2 | 15 | 99.93 | 0.93 | 99.84 | -0.09 | |
| HOMO-2412-B2307 | BPC-157 | 30 Dec 2024 | 2025-Q2 | 6 | 99.29 | 0.94 | 99.90 | +0.61 | SHARED BULK |
| HOMO-2412-V2760 | Retatrutide | 22 Dec 2024 | 2025-Q2 | 5 | 98.61 | 1.45 | 98.91 | +0.30 | |
| HOMO-2412-B9129 | PEG-MGF | 19 Dec 2024 | 2025-Q2 | 3 | 98.47 | 0.24 | 98.82 | +0.35 | |
| HOMO-2411-P1141 | KPV | 25 Nov 2024 | 2025-Q1 | 13 | 99.28 | 1.23 | 99.56 | +0.28 | |
| HOMO-2411-S1486 | N-Acetyl Semax Amide | 18 Nov 2024 | 2024-Q4 | 1 | 99.63 | n<2 | 99.90 | +0.27 | |
| HOMO-2411-K9540 | BPC-157 | 03 Nov 2024 | 2025-Q1 | 3 | 99.71 | 0.39 | 99.90 | +0.19 | |
| HOMO-2410-E8462 | TB-500 | 23 Oct 2024 | 2025-Q1 | 11 | 99.70 | 0.89 | 99.90 | +0.20 | |
| HOMO-2410-K1981 | SS-31 (Elamipretide) | 15 Oct 2024 | 2024-Q4 | 10 | 99.93 | 0.55 | 99.90 | -0.03 | |
| HOMO-2409-R9317 | Retatrutide | 05 Sep 2024 | 2025-Q1 | 4 | 99.50 | 1.17 | 99.90 | +0.40 | |
| HOMO-2408-C8560 | GHK-Cu | 30 Aug 2024 | 2024-Q3 | 6 | 99.01 | 1.07 | 99.21 | +0.20 | |
| HOMO-2408-G1480 | BPC-157 | 27 Aug 2024 | 2024-Q3 | 1 | 99.00 | n<2 | 99.70 | +0.70 | |
| HOMO-2408-P9247 | PT-141 (Bremelanotide) | 16 Aug 2024 | 2024-Q4 | 10 | 99.67 | 1.12 | 100.00 | +0.33 | |
| HOMO-2408-A1230 | Humanin (HNG) | 12 Aug 2024 | 2025-Q1 | 11 | 99.71 | 0.72 | 99.90 | +0.19 | |
| HOMO-2408-R8352 | L-Glutathione (reduced) | 06 Aug 2024 | 2025-Q1 | 3 | 99.67 | 0.27 | 100.50 | +0.83 | |
| HOMO-2407-P1771 | Retatrutide | 27 Jul 2024 | 2024-Q3 | 7 | 98.55 | 0.83 | 98.50 | -0.05 | |
| HOMO-2407-T9333 | GHRP-6 | 20 Jul 2024 | 2024-Q3 | 3 | 99.60 | 0.68 | 99.90 | +0.30 | |
| HOMO-2406-F1206 | Survodutide | 18 Jun 2024 | 2024-Q4 | 9 | 99.57 | 0.94 | 99.82 | +0.25 | |
| HOMO-2406-T9782 | Retatrutide | 13 Jun 2024 | 2024-Q3 | 4 | 98.59 | 0.86 | 99.00 | +0.41 | |
| HOMO-2405-U8504 | Oxytocin | 28 May 2024 | 2024-Q3 | 2 | 99.93 | 0.00 | 99.90 | -0.03 | |
| HOMO-2405-T8995 | BPC-157 | 22 May 2024 | 2024-Q3 | 5 | 99.26 | 0.76 | 99.75 | +0.49 | |
| HOMO-2405-P1520 | L-Carnosine | 20 May 2024 | 2024-Q2 | 10 | 99.48 | 0.94 | 99.90 | +0.42 | |
| HOMO-2405-B9038 | Retatrutide | 18 May 2024 | 2024-Q3 | 5 | 97.76 | 1.09 | 98.50 | +0.74 | |
| HOMO-2404-S1925 | Retatrutide | 01 Apr 2024 | 2024-Q3 | 9 | 98.41 | 1.66 | 98.98 | +0.57 | |
| HOMO-2401-X1480 | N-Acetyl Semax Amide | 17 Jan 2024 | 2024-Q1 | 14 | 99.25 | 1.32 | 99.90 | +0.65 | |
| HOMO-2401-J8536 | MK-677 (Ibutamoren mesylate) | 17 Jan 2024 | 2024-Q2 | 5 | 99.66 | 0.41 | 99.90 | +0.24 | |
| HOMO-2401-R8471 | Semaglutide | 07 Jan 2024 | 2024-Q2 | 2 | 99.51 | 0.85 | 99.45 | -0.06 | |
| HOMO-2311-M9561 | Semaglutide | 22 Nov 2023 | 2024-Q2 | 3 | 98.94 | 1.23 | 98.99 | +0.05 | |
| HOMO-2311-R2091 | Retatrutide | 17 Nov 2023 | 2024-Q2 | 6 | 98.02 | 1.47 | 98.77 | +0.75 | |
| HOMO-2311-M1880 | MOTS-c | 11 Nov 2023 | 2024-Q2 | 1 | 98.65 | n<2 | 99.38 | +0.73 | |
| HOMO-2308-R8982 | TB-500 | 10 Aug 2023 | 2024-Q1 | 3 | 99.23 | 0.38 | 100.50 | +1.27 |